Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for metabolic effects of olanzapine in schizophrenia
IRCT201107187049N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin and olanzapine in schizophrenia (2 arms), sponsored by Guilan University of Medical Sciences. Started Aug 2011; status: completed.
02
Drugs
melatoninolanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201107187049N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201107187049N1.